M Yanartas1, A Baysal2, C Aydın3, Y Ay3, I Kara4, E Aydın1, D Cevirme1, C Köksal1, H Sunar1. 1. Cardiovascular Surgery Clinic, Kartal Kosuyolu High, Speciality Training and Research Hospital Istanbul, Turkey. 2. Anesthesiology and Reanimation Clinic, Kartal Kosuyolu High, Speciality Training and Research Hospital Istanbul, Turkey. 3. Cardiovascular Surgery Clinic, Bezm-i Alem University Medical Faculty Istanbul, Turkey. 4. Cardiovascular Surgery Clinic, Sakarya University Medical Faculty Sakarya, Turkey.
Abstract
BACKGROUND: The addition of 6% hydroxyethyl starch (HES) into Ringer lactate priming solution may have adverse effects on hemostasis in patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) with or without the use oftranexamic acid. METHODS: In a prospective, randomized clinical trial, 132 patients were assigned to receive 20 ml/kg of Ringer priming solution with or without tranexamic acid (TA) (Group RS-TA, n=34 and Group RS-noTA, n=32) or 10 ml/kg of 6% HES plus 10 ml/kg of RS priming solution with or without intravenous tranexamic acid (Group HES-TA, n=35 and Group HES-noTA, n=31). Estimated blood loss, chest tube drainage, amount of blood products, hemoglobin, hematocrit, platelet and coagulation parameters were examined before and 24 hour after surgery. RESULTS: For Group HES with tranexamic acid, when compared to other groups, estimated blood loss, postoperative 24 hour drainage loss and blood product transfusions were less (P=0.023; P=0.003; P=0.001; respectively) and hemoglobin, hematocrit values at 12 and 24 hours after surgery increased in comparison to other groups (P=0.041, P=0.034, P=0.004, P=0.001; respectively). Platelet concentrations were similar between groups (P>0.05). CONCLUSIONS: In CABG, the administration of tranexamic acid in HES 130/0.4 prime solution study group decreased estimated blood loss and chest tube drainage in comparison to patients receving Ringer prime solution with or without tranexamic acid postoperatively however, no effects on renal functions or postoperative complications were shown.
RCT Entities:
BACKGROUND: The addition of 6% hydroxyethyl starch (HES) into Ringer lactate priming solution may have adverse effects on hemostasis in patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) with or without the use of tranexamic acid. METHODS: In a prospective, randomized clinical trial, 132 patients were assigned to receive 20 ml/kg of Ringer priming solution with or without tranexamic acid (TA) (Group RS-TA, n=34 and Group RS-noTA, n=32) or 10 ml/kg of 6% HES plus 10 ml/kg of RS priming solution with or without intravenous tranexamic acid (Group HES-TA, n=35 and Group HES-noTA, n=31). Estimated blood loss, chest tube drainage, amount of blood products, hemoglobin, hematocrit, platelet and coagulation parameters were examined before and 24 hour after surgery. RESULTS: For Group HES with tranexamic acid, when compared to other groups, estimated blood loss, postoperative 24 hour drainage loss and blood product transfusions were less (P=0.023; P=0.003; P=0.001; respectively) and hemoglobin, hematocrit values at 12 and 24 hours after surgery increased in comparison to other groups (P=0.041, P=0.034, P=0.004, P=0.001; respectively). Platelet concentrations were similar between groups (P>0.05). CONCLUSIONS: In CABG, the administration of tranexamic acid in HES 130/0.4 prime solution study group decreased estimated blood loss and chest tube drainage in comparison to patients receving Ringer prime solution with or without tranexamic acid postoperatively however, no effects on renal functions or postoperative complications were shown.
Authors: T J Gan; E Bennett-Guerrero; B Phillips-Bute; H Wakeling; D M Moskowitz; Y Olufolabi; S N Konstadt; C Bradford; P S Glass; S J Machin; M G Mythen Journal: Anesth Analg Date: 1999-05 Impact factor: 5.108
Authors: Alexey A Schramko; Raili T Suojaranta-Ylinen; Anne H Kuitunen; Sinikka I Kukkonen; Tomi T Niemi Journal: Anesth Analg Date: 2009-01 Impact factor: 5.108
Authors: Hasan Alper Gurbuz; Ahmet Baris Durukan; Nevriye Salman; Murat Tavlasoglu; Elif Durukan; Halil İbrahim Ucar; Cem Yorgancioglu Journal: J Cardiothorac Surg Date: 2013-04-08 Impact factor: 1.637
Authors: Anne Maria Beukers; Jamy Adriana Catharina de Ruijter; Stephan Alexander Loer; Alexander Vonk; Carolien Suzanna Enna Bulte Journal: Interact Cardiovasc Thorac Surg Date: 2022-08-03